JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB200659

Anti-NCAPH2 antibody [EPR17170]

4

(1 Review)

|

(3 Publications)

Rabbit Recombinant Monoclonal NCAPH2 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human, Mouse, Rat samples. Cited in 3 publications.

View Alternative Names

CAPH2, NCAPH2, Condensin-2 complex subunit H2, Chromosome-associated protein H2, Kleisin-beta, Non-SMC condensin II complex subunit H2, hCAP-H2

11 Images
Flow Cytometry (Intracellular) - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-NCAPH2 antibody [EPR17170] (AB200659)

ab200659 staining NCAPH2 in Jurkat (human acute T cell leukemia) cellsby intracellular flow cytometry. Cells were fixed with 4% paraformaldehyde and the sample was incubated with the primary antibody at a dilution of 1/240. A goat anti rabbit IgG (Alexa Fluor® 488) at a dilution of 1/2000 was used as the secondary antibody.

Isoytype control : Rabbit monoclonal IgG (Black)

Unlabelled control : Cell without incubation with primary antibody and secondary antibody (Blue)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NCAPH2 antibody [EPR17170] (AB200659)

Immunohistochemical analysis of paraffin-embedded Human hepatocellular carcinoma tissue labeling NCAPH2 with ab200659 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution.

Nuclear and weakly cytoplasmic staining on Human hepatocellular carcinoma is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NCAPH2 antibody [EPR17170] (AB200659)

Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling NCAPH2 with ab200659 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution.

Nuclear and weakly cytoplasm staining on Human tonsil tissue is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NCAPH2 antibody [EPR17170] (AB200659)

Immunohistochemical analysis of paraffin-embedded Human clear cell carcinoma of kidney tissue labeling NCAPH2 with ab200659 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution.

Nuclear and cytoplasm staining on Human clear cell carcinoma of kidney tissue is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-NCAPH2 antibody [EPR17170] (AB200659)

Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized Jurkat (Human T cell leukemia cells from peripheral blood) cells labeling NCAPH2 with ab200659 at 1/100 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green).

Nuclear and weakly cytoplasm staining on Jurkat cell line is observed.

The nuclear counter stain is DAPI (blue).

Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).
The negative controls are as follows :
-ve control 1 : ab200659 at 1/100 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/500 dilution.

Immunocytochemistry/ Immunofluorescence - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-NCAPH2 antibody [EPR17170] (AB200659)

Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling NCAPH2 with ab200659 at 1/100 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green).

Nuclear and weakly cytoplasm staining on HeLa cell line is observed.

The nuclear counter stain is DAPI (blue).

Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).
The negative controls are as follows :
-ve control 1 : ab200659 at 1/100 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/500 dilution.

Immunoprecipitation - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • IP

Supplier Data

Immunoprecipitation - Anti-NCAPH2 antibody [EPR17170] (AB200659)

NCAPH2 was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate with ab200659 at 1/60 dilution.

Western blot was performed from the immunoprecipitate using ab200659 at 1/1000 dilution.

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.

Lane 1 : HeLa whole cell lysate 10 μg (Input).

Lane 2 : ab200659 IP in HeLa whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab200659 in HeLa whole cell extract.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-NCAPH2 antibody [EPR17170] (ab200659)

Predicted band size: 68 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NCAPH2 antibody [EPR17170] (AB200659)

Immunohistochemical analysis of paraffin-embedded Rat kidney tissue labeling NCAPH2 with ab200659 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution.

Nuclear and weakly cytoplasmic staining on rat kidney is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Western blot - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • WB

Supplier Data

Western blot - Anti-NCAPH2 antibody [EPR17170] (AB200659)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-NCAPH2 antibody [EPR17170] (ab200659) at 1/10000 dilution

Lane 1:

HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 2:

HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 20 µg

Lane 3:

Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 68 kDa

Observed band size: 68 kDa

false

Exposure time: 15s

Western blot - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • WB

Supplier Data

Western blot - Anti-NCAPH2 antibody [EPR17170] (AB200659)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-NCAPH2 antibody [EPR17170] (ab200659) at 1/1000 dilution

Lane 1:

RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg

Lane 2:

PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 68 kDa

Observed band size: 68 kDa

false

Exposure time: 15s

Western blot - Anti-NCAPH2 antibody [EPR17170] (AB200659)
  • WB

Supplier Data

Western blot - Anti-NCAPH2 antibody [EPR17170] (AB200659)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-NCAPH2 antibody [EPR17170] (ab200659) at 1/1000 dilution

Lane 1:

Mouse heart lysate at 10 µg

Lane 2:

Rat heart lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 68 kDa

Observed band size: 68 kDa

false

Exposure time: 3min

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR17170

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IP, IHC-P, ICC/IF, WB, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Alternative Products

Primary Antibodies

AB221722

Anti-NCAPH2 antibody

Immunocytochemistry/ Immunofluorescence - Anti-NCAPH2 antibody (AB221722)

  • 5
  • 1

Complementary Products

Primary Antibodies

AB154105

Anti-BRRN1 antibody

Immunocytochemistry/ Immunofluorescence - Anti-BRRN1 antibody (AB154105)

  • 4
  • 1
Primary Antibodies

AB300040

Anti-SMARCA6 antibody [EPR25295-62]

BOND RX™ Validated|20ul selling size|RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SMARCA6 antibody [EPR25295-62] (AB300040)

  • 0
  • 0
Primary Antibodies

AB32140

Anti-Daxx antibody [E94]

20ul selling size|RabMAb|Recombinant|KO Validated

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Daxx antibody [E94] (AB32140)

  • 2
  • 1
Primary Antibodies

AB228729

Anti-HKDC1 antibody

Immunocytochemistry/ Immunofluorescence - Anti-HKDC1 antibody (AB228729)

  • 0
  • 0
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/60", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "10 µg/mL", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p></p>" } } }
style
left-column

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

NCAPH2 also known as non-SMC condensin II complex subunit H2 plays an important role in chromosome condensation. It is a part of the condensin II complex and contributes to the structuring and stabilization of chromatin. NCAPH2 has a mass of approximately 99 kDa and is expressed broadly in various tissues including embryonic tissues and adult organs. Its functional role is important in processes that require chromatin reorganization.
Biological function summary

NCAPH2 functions as an important component of the condensin II complex which facilitates proper chromosome segregation during cell division. The protein through its interaction with other condensin subunits C and A oversees the maintenance of chromosome architecture. It also influences mitotic progression by ensuring the accurate separation of sister chromatids. Research shows NCAPH2's involvement in maintaining genome stability highlighting its biological significance.

Pathways

NCAPH2 participates in important cellular pathways such as mitotic chromosome condensation and DNA repair mechanisms. Within these pathways NCAPH2 interacts closely with proteins like SMC2 and SMC4 which form the core of the condensin complexes. Correct functioning of these pathways ensures the integrity of genetic material during cell division preventing aneuploidy and other chromosomal abnormalities.

NCAPH2 has been linked to various conditions including cancer and developmental disorders. Its dysregulation has associations with certain cancers due to its role in maintaining genomic stability where its aberrant expression may lead to improper cell division and tumorigenesis. Additionally connections to Kleefstra syndrome where a disruption impacts chromatin organization suggest NCAPH2's interactions with other chromatin-modifying proteins including histone deacetylases.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Regulatory subunit of the condensin-2 complex, a complex that seems to provide chromosomes with an additional level of organization and rigidity and in establishing mitotic chromosome architecture (PubMed : 14532007). May promote the resolution of double-strand DNA catenanes (intertwines) between sister chromatids. Condensin-mediated compaction likely increases tension in catenated sister chromatids, providing directionality for type II topoisomerase-mediated strand exchanges toward chromatid decatenation. Required for decatenation of chromatin bridges at anaphase. Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size (By similarity). Seems to have lineage-specific role in T-cell development (PubMed : 14532007).
See full target information NCAPH2
style
left-column

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Journal of ovarian research 18:81 PubMed40259316

2025

NCAPH promotes glucose metabolism reprogramming and cell stemness in ovarian cancer cells through the MEK/ERK/PD-L1 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yingying Qi,Aiping Wang,Silin Chen,Wei Chen

Nature communications 16:1675 PubMed39955279

2025

SRBD1 facilitates chromosome segregation by promoting topoisomerase IIα localization to mitotic chromosomes.

Applications

Unspecified application

Species

Unspecified reactive species

Courtney A Lovejoy,Sarah R Wessel,Rahul Bhowmick,Yuki Hatoyama,Masato T Kanemaki,Runxiang Zhao,David Cortez

NPJ Regenerative medicine 8:25 PubMed37217533

2023

A superior extracellular matrix binding motif to enhance the regenerative activity and safety of therapeutic proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Yasmin K Alshoubaki,Yen-Zhen Lu,Julien M D Legrand,Rezvan Karami,Mathilde Fossat,Ekaterina Salimova,Ziad Julier,Mikaël M Martino
View all publications
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com